Pharmacogenetics of alcohol, nicotine and drug addiction treatments

A genetic determinant of the striatal dopamine response to alcohol in men

(2010) V A Ramchandani et al.   MOLECULAR PSYCHIATRY

Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators

(2009) Wendy Ooteman et al.   ADDICTION BIOLOGY

Suppression of Alcohol Preference by Naltrexone in the Rhesus Macaque: A Critical Role of Genetic Variation at the μ-Opioid Receptor Gene Locus

(2009) Christina S. Barr et al.   BIOLOGICAL PSYCHIATRY

Nicotinic Acetylcholine Receptor  2 Subunit (CHRNB2) Gene and Short-Term Ability to Quit Smoking in Response to Nicotine Patch

(2009) K. A. Perkins et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE Study

(2009) Lara A. Ray et al.   DRUG AND ALCOHOL DEPENDENCE

Cigarette Smoking Among Adults—United States, 2007

(2009)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mechanisms of Disulfiram-induced Cocaine Abstinence: Antabuse and Cocaine Relapse

(2009) M. Gaval-Cruz et al.   MOLECULAR INTERVENTIONS

What We Know: Findings That Every Theory of Schizophrenia Should Explain

(2009) A. W. MacDonald et al.   SCHIZOPHRENIA BULLETIN

Multiple genetic tests for susceptibility to smoking do not outperform simple family history

(2008) Coral E. Gartner et al.   ADDICTION

[Commentary] THE CLINICAL UTILITY OF GENETIC TESTS

(2008)   ADDICTION

Effects of Opioid Receptor Gene Variation on Targeted Nalmefene Treatment in Heavy Drinkers

(2008) Albert J. Arias et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Molecular Genetics of Successful Smoking Cessation

(2008) George R. Uhl et al.   ARCHIVES OF GENERAL PSYCHIATRY

An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence

(2008) Raymond F. Anton et al.   ARCHIVES OF GENERAL PSYCHIATRY

Norepinephrine Signaling Through β-Adrenergic Receptors is Critical for Expression of Cocaine-Induced Anxiety

(2008) Jesse R. Schank et al.   BIOLOGICAL PSYCHIATRY

Correlation of Plasma Dopamine β-hydroxylase Activity with Polymorphisms in DBH Gene: A Study on Eastern Indian Population

(2008) Nipa Bhaduri et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion

(2008) F Patterson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation

(2008) David V. Conti et al.   HUMAN MOLECULAR GENETICS

Pharmacogenomics: The Promise of Personalized Medicine for CNS Disorders

(2008) Jose de Leon   NEUROPSYCHOPHARMACOLOGY

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation

(2008) Nicky Welton et al.   NICOTINE & TOBACCO RESEARCH

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study

(2008) Robert A. Schnoll et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients

(2008) Sung-Gon Kim et al.   PSYCHOPHARMACOLOGY